369 related articles for article (PubMed ID: 11940661)
21. MAP kinase module: the Ksr connection.
Roy F; Therrien M
Curr Biol; 2002 Apr; 12(9):R325-7. PubMed ID: 12007434
[TBL] [Abstract][Full Text] [Related]
22. IL-2 activation of NK cells: involvement of MKK1/2/ERK but not p38 kinase pathway.
Yu TK; Caudell EG; Smid C; Grimm EA
J Immunol; 2000 Jun; 164(12):6244-51. PubMed ID: 10843677
[TBL] [Abstract][Full Text] [Related]
23. Kinase suppressor of Ras couples Ras to the ERK cascade during T cell development.
Laurent MN; Ramirez DM; Alberola-Ila J
J Immunol; 2004 Jul; 173(2):986-92. PubMed ID: 15240686
[TBL] [Abstract][Full Text] [Related]
24. JSAP1, a novel jun N-terminal protein kinase (JNK)-binding protein that functions as a Scaffold factor in the JNK signaling pathway.
Ito M; Yoshioka K; Akechi M; Yamashita S; Takamatsu N; Sugiyama K; Hibi M; Nakabeppu Y; Shiba T; Yamamoto KI
Mol Cell Biol; 1999 Nov; 19(11):7539-48. PubMed ID: 10523642
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation regulates the nucleocytoplasmic distribution of kinase suppressor of Ras.
Brennan JA; Volle DJ; Chaika OV; Lewis RE
J Biol Chem; 2002 Feb; 277(7):5369-77. PubMed ID: 11741955
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel human kinase supporter of Ras (hKSR-2) that functions as a negative regulator of Cot (Tpl2) signaling.
Channavajhala PL; Wu L; Cuozzo JW; Hall JP; Liu W; Lin LL; Zhang Y
J Biol Chem; 2003 Nov; 278(47):47089-97. PubMed ID: 12975377
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism.
Romerio F; Riva A; Zella D
Br J Cancer; 2000 Aug; 83(4):532-8. PubMed ID: 10945503
[TBL] [Abstract][Full Text] [Related]
28. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1.
Müller J; Ory S; Copeland T; Piwnica-Worms H; Morrison DK
Mol Cell; 2001 Nov; 8(5):983-93. PubMed ID: 11741534
[TBL] [Abstract][Full Text] [Related]
29. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway.
Park JI; Strock CJ; Ball DW; Nelkin BD
Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453
[TBL] [Abstract][Full Text] [Related]
30. The p38 pathway provides negative feedback for Ras proliferative signaling.
Chen G; Hitomi M; Han J; Stacey DW
J Biol Chem; 2000 Dec; 275(50):38973-80. PubMed ID: 10978313
[TBL] [Abstract][Full Text] [Related]
31. Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation.
Razidlo GL; Kortum RL; Haferbier JL; Lewis RE
J Biol Chem; 2004 Nov; 279(46):47808-14. PubMed ID: 15371409
[TBL] [Abstract][Full Text] [Related]
32. KSR as a therapeutic target for Ras-dependent cancers.
Neilsen BK; Frodyma DE; Lewis RE; Fisher KW
Expert Opin Ther Targets; 2017 May; 21(5):499-509. PubMed ID: 28333549
[TBL] [Abstract][Full Text] [Related]
33. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
34. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways.
Gu J; Tamura M; Yamada KM
J Cell Biol; 1998 Nov; 143(5):1375-83. PubMed ID: 9832564
[TBL] [Abstract][Full Text] [Related]
35. Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression.
Cacace AM; Michaud NR; Therrien M; Mathes K; Copeland T; Rubin GM; Morrison DK
Mol Cell Biol; 1999 Jan; 19(1):229-40. PubMed ID: 9858547
[TBL] [Abstract][Full Text] [Related]
36. Ras participates in the activation of p38 MAPK by interleukin-1 by associating with IRAK, IRAK2, TRAF6, and TAK-1.
McDermott EP; O'Neill LA
J Biol Chem; 2002 Mar; 277(10):7808-15. PubMed ID: 11744690
[TBL] [Abstract][Full Text] [Related]
37. Cell-cycle-dependent activation of mitogen-activated protein kinase kinase (MEK-1/2) in myeloid leukemia cell lines and induction of growth inhibition and apoptosis by inhibitors of RAS signaling.
Morgan MA; Dolp O; Reuter CW
Blood; 2001 Mar; 97(6):1823-34. PubMed ID: 11238126
[TBL] [Abstract][Full Text] [Related]
38. A CC-SAM, for coiled coil-sterile α motif, domain targets the scaffold KSR-1 to specific sites in the plasma membrane.
Koveal D; Schuh-Nuhfer N; Ritt D; Page R; Morrison DK; Peti W
Sci Signal; 2012 Dec; 5(255):ra94. PubMed ID: 23250398
[TBL] [Abstract][Full Text] [Related]
39. Age-related reductions in the activation of mitogen-activated protein kinases p44mapk/ERK1 and p42mapk/ERK2 in human T cells stimulated via ligation of the T cell receptor complex.
Whisler RL; Newhouse YG; Bagenstose SE
Cell Immunol; 1996 Mar; 168(2):201-10. PubMed ID: 8640866
[TBL] [Abstract][Full Text] [Related]
40. KSR regulation of the Raf-MEK-ERK cascade.
Ritt DA; Daar IO; Morrison DK
Methods Enzymol; 2006; 407():224-37. PubMed ID: 16757327
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
